Transfers of cellular components occur through structures that are highly heterogeneous, and they have been seen in multiple contexts. As a result, there has been a profusion of names to describe them. The most common names are microvesicles or microparticles (MVs/MPs), terms used to include fragments of plasma membrane, and specialized extra cellular organelles, such as nanotubes and filopodia 5 . But cell-to-cell communication through MVs/ MPs poses enormous difficulties in defining regulation and control of the process. In effect, the observations require a conceptual leap from the seductive paradigm that the fates of cells are primarily controlled by ligand-receptor interactions on the plasma membrane that are transmitted by signaling pathways to the nucleus.
Until recently, transfer of a mitochondrion seemed beyond the capacity of MVs/MPs. Mitochondria were first shown to be transferred between cells though filopodia-like extensions in co-cultures of BMSCs and a line of lung epithelial cells with nonfunctioning mitochondria (A549 ρ 0 cells) 11 . Two subsequent publications-where human BMSCs were co-cultured with rat cardiomyocytes 12 or with human osteosarcoma cells depleted of functional mitochondria 13 -confirmed this cell-to-cell transfer phenomenon, but only in vitro. One of the first indications that mitochondrial transfer might occur in vivo came from the unusual observation that the host mitochondrial DNA was found in a venereal tumor transmitted in feral dogs 14 . The report by Islam et al. 8 , however, is the first demonstration that transfer of intact mitochondria can contribute to tissue repair in vivo (Fig. 1) .
One consequence of the evidence of mitochondrial transfer is that the phenomenon probably explains some of the beneficial effects that have been observed with administration of BMSCs in animal models for a large number of diseases 10 . These BMSCs were originally thought to repair tissues by engrafting and differentiating to replace injured cells; however, beneficial effects were commonly observed without long-term engraftment of the cells. Instead, they seem to repair tissues, or limit damage from excessive inflammatory and immune responses, by being activated by signals from the injured tissues to secrete a large number of paracrine factors. Given that BMSCs remain in most tissues for only a short time, the sequence was referred to as 'kiss and run' . Islam et al. 8 suggest a 'Trojan horse' effect in transferring mitochondria, even though they point out that their results do not exclude the possibility that paracrine factors secreted by the BMSCs may have contributed to the tissue repair they observed.
The transfer of functional mitochondria to injured cells can itself have profound effects, as any decrease in reduction of oxygen by mitochondria generates highly toxic reactive oxygen species. The reactive oxygen species, in turn, activate inflammasomes and other components that trigger the normal cascade of inflammatory and immune responses. Many diseases are now recognized to involve tissue destruction from excessive or unresolved inflammation 10 . Therefore, transfers of functional mitochondria to cardiomyocytes during a myocardial infarction or to neurons during a stroke could interrupt a deadly progression of events. And perhaps therapies with mitochondria, instead of cells, might be possible for some diseases. In one series of experiments 10 , adding isolated mitochondria to cultures of mitochondria-defective cells had no effect; however, the possibility was not explored in detail.
The observations on mitochondrial transfers may have much broader implications. To date, it has only been seen from BMSCs, cells that are found in the adventitia of most blood vessels and that are mobilized by tissue injury 10 . It seems likely that some of the many other types of cells that participate in tissue repair can also serve as donors of mitochondria. Moreover, in three reports 8, 10, 13 , the transfer has only been seen if the target cells had nonfunctional mitochondria or were exposed to the toxic effects of LPS. Therefore, it seems likely that transfer of mitochondria from several kinds of donor cells to injured cells may be a key component of tissue repair in many pathological conditions.
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has long been known to disrupt the intestinal homeostasis, predisposing the host to infections with antibiotic-resistant pathogens 2 . In this issue of Nature Medicine, Ayers et al. 3 provide a detailed account of the lethal consequences of antibiotic-induced disturbance of the intestinal microbiota and the detrimental role of the innate immune system in decreasing tolerance in this setting.
Trillions of bacteria colonize the lower intestinal tract in mammalian species. The composition, diversity and stability of the intestinal microbial ecosystems have recently become a subject of intense investigation and a rich source of surprising findings. One notion that quickly emerged from these studies is that loss of microbial diversity in colonized tissues tends to be associated with deleterious effects on the host 1 . Oral administration of antibiotics has one of the most powerful impacts on microbial composition and diversity and Depletion of resident bacteria (symbionts) that normally dominate the intestinal niches resulted in the overgrowth of an antibioticresistant strain of pathogenic Escherichia coli (E. coli O21:H+) (Fig. 1) . Interestingly, the virulence gene cluster of E. coli O21:H+ has a characteristic feature shared with other septicemic E. coli 3 . Indeed, invasion of E. coli O21:H+ into the systemic circulation caused a sepsislike condition with severe inflammatory tissue damage in multiple organs 3 . This invasion was facilitated by DSS-mediated disruption of intestinal barrier integrity. However, intravenous injection of the bacteria into mice untreated with DSS was sufficient to cause sepsis and mortality, confirming the connection between this particular pathogen and the disease.
Notably, the lethal systemic inflammatory response triggered by E. coli O21:H+ was dependent on the production of interleukin-1 (IL-1β) through the activation of NAIP5-NLRC4 inflammasome in macrophages. Inflammasomes are intracellular protein complexes that control proteolytic processing and secretion of IL-1β and several other inflammatory mediators 6 . NAIP5-NLRC4 recognizes bacterial flagellin 7 , which can be secreted into the host cell through the specialized secretory apparatus known as the ETT2 type 3 secretion system (T3SS) 8, 9 . The E. coli O21:H+ isolated by Ayers et al. 3 and related septicemic bacteria share a genetic variation (known as ETT2 sepsis ) affecting their T3SS, suggesting that ETT2 sepsis may be particularly prone to flagellin secretion. It would be interesting to determine in future studies whether all bacteria expressing this particular version of the T3SS can cause sepsis through the flagellin-NLRC4-IL-1β pathway. This could inform the choice of therapy (such as IL-1 blockade) for patients with sepsis, as sepsis can be caused by more than one mechanism and in some settings TNF-α has a more dominant role compared to IL-1β 10 .
Immunopathology, such as collateral tissue damage caused by the immune response, is often an unavoidable cost of host defense against infections. The clinical challenge of dealing with immunopathology is that reducing the immune response can compromise host protection from an ongoing infection. How to strike the right balance between optimal host protection and minimal immunopathology is not always clear, and it requires a detailed knowledge of the relative contribution of different host defense mechanisms to protection versus disease. In that context, another key finding by the authors is that the NLRC4-IL-1β pathway does not seem to contribute to the clearance of the pathogenic E. coli O21:H+, as blocking this pathway did not affect pathogen burden, even though it did improve
The study by Ayers et al. 3 shows how anti biotic treatment affects intestinal epithelial damage caused by dextran sodium sulfate (DSS). DSS is toxic to colonic epithelium, and its oral administration is a convenient and widely used model of intestinal damage and colitis. Antibiotic-induced depletion of commensal bacteria was previously shown to increase susceptibility to DSS-induced intestinal injury 5 . In that model, commensal bacteria provided ligands for Toll-like receptor (TLR) stimulation, which, in turn, was necessary to promote epithelial tissue protection and repair. In the experimental model used by Ayers et al. 3 , antibiotic administration after DSS treatment resulted in severe mortality, but the cause of the problem seems to be a disruption of normal intestinal bacterial composition by antibiotics rather than a lack of stimulation. Studies in germ-free animals have long established a crucial role of microbial colonization in the gut for normal development and physiology of the host organism 4 . Administration of broad-spectrum antibiotics to adult mice bypasses the developmental effects of colonization and can recapitulate some of the phenotypes of germ-free mice, such as alteration of intestinal epithelial homeostasis and increased susceptibility to damage 5 . However, antibiotics do not completely sterilize the intestinal lumen, and antibiotic-resistant bacterial strains can greatly expand in the newly available niches. The consequences of such an expansion depend on the host status-for example, barrier integrity and immune competence-as well as on the identity of the antibiotic-resistant bacteria. 3 show that antibiotic-mediated depletion of symbionts leads to expansion of antibiotic-resistant pathobionts; however, an intact epithelial barrier prevents their invasion (top right). Disruption of epithelial integrity (as occurs after DSSinduced colitis) can lead to a transient invasion of symbionts, but these are rapidly cleared by the immune system (bottom left). In the context of antibiotic-induced dysbiosis, however, disruption of the epithelial barrier leads to invasion of pathobionts and subsequent septicemia. E. coli O21:H+ carries a variant of a virulence gene cluster known as ETT2 sepsis , which may promote flagellin secretion through the T3SS. Flagellin secreted into host macrophages activates the NAIP5-NLRC4-IL-1β pathway, ultimately leading to multiple organ damage caused by the systemic inflammatory effects of IL-1β. 
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Marina Corral npg host survival 3 . This indicates that in this model of sepsis, interfering with the NAIP5-NLRC4-IL-1 β pathway might be beneficial without having negative consequences for host immunity. Furthermore, it can be therapeutic even in the face of high bacterial burden, which can be particularly relevant for antibioticresistant pathogens such as E. coli O21:H+. Indeed, when infections progress to sepsis, the inflammatory response is a far greater evil than the direct tissue damage by the pathogen-at that stage, suppressing pathogen load alone has a limited therapeutic value. Therefore, identifying the pathways responsible for the inflammatory tissue damage but dispensable for host immunity, as done by Ayers et al. 3 , is of utmost importance. Finally, the study by Ayers et al. 3 highlights another key emerging issue: the notion of pathobionts, microorganisms that can be part of the normal microbiota in healthy hosts but that can cause disease when some aspect of host-microbial homeostasis is disrupted 11 . The difference between pathobionts and opportunistic pathogens is that the latter are traditionally thought to be able to cause the disease when the host immunity is compromised. The definition of pathobionts can be considerably broader, as their pathogenic potential can be unleashed by multiple factors, particularly alterations of microbial ecology in the colonized host 12 . Perhaps the most famous microorganism exemplifying this principle is Helicobacter pylori-although more than half of humans harbor this bacterium in their stomachs, only a fraction of them develop ulcers 13 . The distinctions between beneficial commensal microbes, pathobionts and pathogens are not absolute, yet the emerging evidence suggests that, in a given host, the presence and relative abundance of pathobionts seem to determine the susceptibility to multiple inflammatory diseases 14, 15 . The 'germ theory' of disease proposed that many human maladies can be caused by specific pathogens. In the near future, we may expect an expansion of the germ theory to incorporate the pathogenic potential of normal constituents of our microbiota. them for severely obese patients. Among such patients, nonrandomized studies report that bariatric surgery is associated with reductions in cardiovascular risk factors 8 , cardiovascular events 9 and mortality 10, 11 . In contrast, medical or lifestyle interventions for obesity and diabetes have never been proven to reduce cardiovascular events or death.
Despite these compelling clinical observations, RCTs of surgery versus nonsurgery are sorely needed. Ample precedents exist wherein RCTs reversed longstanding paradigms derived from nonrandomized clinical trials 12, 13 . Some of the best evidence in bariatric surgery, from the Swedish Obese Subjects study (a long-term observation of various operations versus conventional care), is prone to allocation bias because participants were not randomized [8] [9] [10] . Subjects who actively chose surgery may be more motivated overall and generally take better care of themselves. The NIH is unlikely to reconsider its guidelines without pertinent RCTs, and insurance To combat the twin pandemics of obesity and type 2 diabetes mellitus (T2DM), clinicians need every tool they can get. Major, durable weight loss is uncommon with medical and/ or behavioral approaches, and adequate glycemic control often remains elusive. Many diabetes drugs promote weight gain, and using them to normalize blood glucose increases the risks of hypoglycemia. The most effective intervention for weight loss and T2DM seems to be bariatric surgery. Because some operations engage weight-independent antidiabetes mechanisms 1,2 , using them to treat T2DM in less-obese patients is under consideration 3, 4 . The full risk/benefit ratio of surgical versus nonsurgical approaches, however, has not been adequately tested. US National Institutes of Health (NIH) guidelines based on body mass index (BMI) criteria for patient selection have governed bariatric surgery for over 20 years 5 . Yet these recommendations were crafted with neither any Level 1 evidence addressing surgical versus nonsurgical methodologies nor an emphasis on T2DM. Now two randomized controlled trials (RCTs) comparing bariatric operations with medical therapy to treat T2DM, including among patients below the usual BMI threshold for surgery, report that surgery yields better glycemic control, diabetes remission and reduction of other cardiovascular risk factors, with seemingly acceptable complications, for 1-2 years 6,7 .
NIH guidelines from 1991 limit bariatric surgery to people with a BMI >40 kg m -2 , or >35 kg m -2 plus obesity-related complications 5 . Although these recommendations were generated without relevant RCTs comparing surgical with nonsurgical care, two decades of clinical observations seem at face value to validate David E. Cummings is at the University of Washington, Seattle, Washington, USA; he is based at the Diabetes & Obesity Center of Excellence and the VA Puget Sound Health Care System, Seattle, Washington, USA. e-mail: davidec@u.washington.edu
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Clinicians note that bariatric operations can dramatically resolve type 2 diabetes, often before and out of proportion to postoperative weight loss. Now two randomized controlled trials formally show superior results from surgical compared with medical diabetes care, including among only mildly obese patients. The concept of 'metabolic surgery' to treat diabetes has taken a big step forward.
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